355 related articles for article (PubMed ID: 33786823)
1. Mechanisms of endocannabinoid transport in the brain.
Kaczocha M; Haj-Dahmane S
Br J Pharmacol; 2022 Sep; 179(17):4300-4310. PubMed ID: 33786823
[TBL] [Abstract][Full Text] [Related]
2. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.
Lee SH; Ledri M; Tóth B; Marchionni I; Henstridge CM; Dudok B; Kenesei K; Barna L; Szabó SI; Renkecz T; Oberoi M; Watanabe M; Limoli CL; Horvai G; Soltesz I; Katona I
J Neurosci; 2015 Jul; 35(27):10039-57. PubMed ID: 26157003
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoid-mediated control of synaptic transmission.
Kano M; Ohno-Shosaku T; Hashimotodani Y; Uchigashima M; Watanabe M
Physiol Rev; 2009 Jan; 89(1):309-80. PubMed ID: 19126760
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid signaling and synaptic function.
Castillo PE; Younts TJ; Chávez AE; Hashimotodani Y
Neuron; 2012 Oct; 76(1):70-81. PubMed ID: 23040807
[TBL] [Abstract][Full Text] [Related]
6. [Lipid mediator endocannabinoids in modulating synaptic transmission].
Hashimotodani Y; Tanimura A; Kano M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Jun; 31(3):105-9. PubMed ID: 21800700
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoids and retrograde modulation of synaptic transmission.
Ohno-Shosaku T; Tanimura A; Hashimotodani Y; Kano M
Neuroscientist; 2012 Apr; 18(2):119-32. PubMed ID: 21531987
[TBL] [Abstract][Full Text] [Related]
8. Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum.
Maejima T; Oka S; Hashimotodani Y; Ohno-Shosaku T; Aiba A; Wu D; Waku K; Sugiura T; Kano M
J Neurosci; 2005 Jul; 25(29):6826-35. PubMed ID: 16033892
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoid liberation from neurons in transsynaptic signaling.
Lovinger DM
J Mol Neurosci; 2007 Sep; 33(1):87-93. PubMed ID: 17901551
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoids and synaptic function in the CNS.
Hashimotodani Y; Ohno-Shosaku T; Kano M
Neuroscientist; 2007 Apr; 13(2):127-37. PubMed ID: 17404373
[TBL] [Abstract][Full Text] [Related]
11. Depolarizing GABAergic synaptic input triggers endocannabinoid-mediated retrograde synaptic signaling.
Urbanski MJ; Kovacs FE; Szabo B
Synapse; 2009 Aug; 63(8):643-52. PubMed ID: 19347961
[TBL] [Abstract][Full Text] [Related]
12. Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.
van der Stelt M; Hansen HH; Veldhuis WB; Bär PR; Nicolay K; Veldink GA; Vliegenthart JF; Hansen HS
Neurotox Res; 2003; 5(3):183-200. PubMed ID: 12835123
[TBL] [Abstract][Full Text] [Related]
13. Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step.
Adermark L; Lovinger DM
Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20564-9. PubMed ID: 18077376
[TBL] [Abstract][Full Text] [Related]
14. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders.
van der Stelt M; Di Marzo V
Eur J Pharmacol; 2003 Nov; 480(1-3):133-50. PubMed ID: 14623357
[TBL] [Abstract][Full Text] [Related]
15. Fatty-acid-binding protein 5 controls retrograde endocannabinoid signaling at central glutamate synapses.
Haj-Dahmane S; Shen RY; Elmes MW; Studholme K; Kanjiya MP; Bogdan D; Thanos PK; Miyauchi JT; Tsirka SE; Deutsch DG; Kaczocha M
Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3482-3487. PubMed ID: 29531087
[TBL] [Abstract][Full Text] [Related]
16. Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation.
Ohno-Shosaku T; Shosaku J; Tsubokawa H; Kano M
Eur J Neurosci; 2002 Mar; 15(6):953-61. PubMed ID: 11918654
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of the endocannabinoid system in the sleep-wake cycle modulation.
Murillo-Rodriguez E; Poot-Ake A; Arias-Carrion O; Pacheco-Pantoja E; Fuente-Ortegon Ade L; Arankowsky-Sandoval G
Cent Nerv Syst Agents Med Chem; 2011 Sep; 11(3):189-96. PubMed ID: 21919868
[TBL] [Abstract][Full Text] [Related]
18. A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling.
Labar G; Wouters J; Lambert DM
Curr Med Chem; 2010; 17(24):2588-607. PubMed ID: 20491633
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid-mediated retrograde modulation of synaptic transmission.
Ohno-Shosaku T; Kano M
Curr Opin Neurobiol; 2014 Dec; 29():1-8. PubMed ID: 24747340
[TBL] [Abstract][Full Text] [Related]
20. Neuronal protease-activated receptor 1 drives synaptic retrograde signaling mediated by the endocannabinoid 2-arachidonoylglycerol.
Hashimotodani Y; Ohno-Shosaku T; Yamazaki M; Sakimura K; Kano M
J Neurosci; 2011 Feb; 31(8):3104-9. PubMed ID: 21414931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
